Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9282-9293
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9282
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9282
Table 1 Tumour regression scoring according to Mandard et al[14]
| Grade | Definition |
| TRG 1 | No residual cancer |
| TRG 2 | Rare residual cancer cells |
| TRG 3 | Fibrosis outgrowing residual cancer |
| TRG 4 | Residual cancer outgrowing fibrosis |
| TRG 5 | Absence of regressive changes |
- Citation: Noble F, Nolan L, Bateman AC, Byrne JP, Kelly JJ, Bailey IS, Sharland DM, Rees CN, Iveson TJ, Underwood TJ, Bateman AR. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World J Gastroenterol 2013; 19(48): 9282-9293
- URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9282.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9282